ArticlePloS one2025
Graph attention networks for predicting drug-gene association of glucocorticoid in oral squamous cell carcinoma: A comparison with GraphSAGE.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe present study evaluates the effectiveness of Graph Attention Networks (GAT) and GraphSAGE in predicting drug-gene interactions for glucocorticoids in oral squamous cell carcinoma, thereby aiding in developing better treatment strategies. MATERIALS AND
methodsWe utilized a curated dataset containing known drug-gene interactions and corresponding molecular profiles. Both GAT and GraphSAGE were implemented to model the biological networks of drug-gene relationships. Experiments were conducted to evaluate each model's performance using accuracy, precision, recall, and F1-score metrics.
resultsThe network analysis details 174 nodes and 409 edges with a sparse structure, moderate connectivity, and low clustering, indicating a diverse node connection. The analysis confirms a fully connected network with efficient computation time. In comparing models, GraphSAGE outperforms GAT with higher accuracy (0.949 vs. 0.947), better macro-averaged F1 score (0.275 vs. 0.195), and higher AUC-ROC (0.780 vs. 0.514), suggesting stronger class-distinction capabilities. Both models achieve high accuracy, but GraphSAGE's superior scores in F1 and AUC-ROC indicate a more effective balance in precision and recall. The results demonstrated that both GAT and GraphSAGE effectively predicted drug-gene associations. However, GAT outperformed GraphSAGE, achieving higher accuracy and F1 scores in identifying relevant glucocorticoid interactions in the context of OSCC.
conclusionOur findings highlight the efficacy of advanced graph-based methodologies in elucidating drug interactions in OSCC. GAT, in particular, shows promise for accurately predicting drug-gene associations, which may facilitate personalized therapeutic approaches. Future research will focus on enhancing these models and exploring additional drug compounds to understand their applicability in OSCC treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.